The intimate and entangled relationship between calmodulin binding proteins and all phases of Alzheimer’s disease has been established, but the relationship to other neurodegenerative diseases is just beginning to be evaluated. This evidence concerns the gene NRGN and early-onset autosomal dominant Alzheimer disease.